Branched Phosphatidylcholines Stimulate Activity of Cytochrome P450SCC (CYP11A1) in Phospholipid Vesicles by Enhancing Cholesterol Binding, Membrane Incorporation, and Protein Exchange*

Pyotr KisselevDagger , Ralf Wessel, Sandra Pisch§, Uwe Bornscheuer§, Rolf-Dieter Schmid§, and Dieter Schwarz

From the Institute of Clinical Pharmacology, Charite-Humboldt University of Berlin, 10098 Berlin/Max Delbrueck Centrum for Molecular Medicine, 13125 Berlin-Buch, Germany, the Dagger  Institute of Bioorganic Chemistry, Academy of Sciences of Belarus, 220141 Minsk, Belarus, and the § Institute for Technical Biochemistry, University Stuttgart, 70569 Stuttgart, Germany

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Phosphatidylcholines (PCs) with branched fatty acyl chains substituted in the two positions of the main chains (branched PCs) have been shown to be potent activators of the side chain cleavage activity of cytochrome P450SCC (CYP11A1) (Schwarz, D., Kisselev, P., Wessel, R., Jueptner, O., and Schmid, R. D. (1996) J. Biol. Chem. 271, 12840-12846). The present study reports on the effect of a series of branched PC on cholesterol binding, membrane integration, and protein exchange in large unilamellar vesicles prepared by an extrusion technique. Enzyme kinetics using vesicles as well as optical titration using a micelle system with the detergent Tween 20 demonstrate that activation is correlated with the fraction of P450SCC in the high spin form. The potency of branched PCs both to activate the enzyme and to induce spin state changes increases with increasing lengths of both the branched and main fatty acyl chains. We found that the extent as well as the rate of integration of P450SCC into vesicle membranes studied by gel chromatography and stopped flow kinetics were increased by branched PC. Finally, it is demonstrated by measurement of the enzymatic activity in primary and secondary vesicles that branched PCs are potent in retaining a very rapid exchange of P450SCC between vesicles, in contrast to cardiolipin, that partially inhibits this exchange process. The data suggest that different properties of P450SCC in membrane systems including cholesterol binding, membrane integration, and protein exchange are affected by branched PCs and probably by other phospholipids, too, and therefore must be considered in an explanation of the observed high stimulation of activity.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cytochrome P450SCC (CYP11A1) is an integral mitochondrial enzyme that is located on the matrix face of the inner membrane of mitochondria. It catalyzes the side chain cleavage of cholesterol to yield pregnenolone, the common precursor of steroid hormones. Enzymatic studies employing both solution (micelle) and membrane (vesicle) systems demonstrated stimulation of activity to varying extent by phospholipids depending on the phospholipid used, the kind of reconstitution, size of vesicles, and small amounts of impurities (for a review see Ref. 1 and references therein and Refs. 2-4). Under the lipids used in reconstitution CL1 played a special role mainly because (i) it is a typical mitochondrial lipid and (ii) it represents the most potent activator of P450SCC activity (5-7). With regard to the mechanism of activation, CL is of further interest because of the exceptional structure of its hydrophobic part, i.e. consisting of four fatty acyl chains instead of two of most other phospholipids.

It has been recently reported by us that certain branched PCs that in the structure of their hydrophobic part are similar to CL but have fully saturated acyl chains cause potent activation of P450SCC comparable only with those by CL (8). By systematic variation of the lengths of both the branched and main chains of these lipids and systematic introduction of unsaturation, we found a relationship between the potency of activation of these PCs and their capacity to increase the propensity of the membrane to form nonbilayer phases. As a major determinant of the potency of activation, we suggested the hydrophobic volume and/or headgroup spacing rather than a specific P450SCC-lipid interaction (9).

A pending question remained regarding the way the branched PCs exert their stimulatory role on the enzymatic activity. It has been shown for CL and other activator lipids that their influence is realized via binding to P450SCC followed by an increase of CHL binding to the enzyme (5-7). Based on preliminary optical measurements in DOPC vesicles, we have suggested (8) that the presence of the branched PCs is related to a significant enhanced content of the high spin form of P450SCC, which is connected with a higher portion of P450SCC to be complexed with its substrate CHL, too. In addition, there are other properties of P450SCC in reconstituted systems that may be affected by branched PCs and lead to subsequent activity increase, e.g. membrane integration into and exchange between vesicles and interaction with its redox partners adrenodoxin and adrenodoxin reductase.

In this paper we justify the conclusion on the importance of increased CHL binding to P450SCC caused by the branched PCs by performing CHL binding experiments to determine the kinetic parameters Km and Vmax for the side chain cleavage reaction as well as by direct spectral titration of the effect of branched PCs on the CHL binding to P450SCC. Further, we show by stationary (gel chromatography) and time-resolved (stopped flow kinetics) experiments that the P450SCC membrane incorporation efficiency is greatly enhanced in the presence of branched PCs with regard to both the rate and the total extent of membrane association. Finally, we demonstrate by measurements of the P450SCC activity in primary and secondary vesicles that the branched PCs are stimulators of or at least retain rapid P450SCC exchange between vesicles (in contrast to CL, which partially inhibits this exchange). It is known that vesicles prepared by detergent removal and sonication often give nonreproducible results because residual detergent and vesicle size heterogeneity have profound influence on the properties of P450SCC mentioned above (2-4). Thus, we used throughout the study large unilamellar vesicles prepared by the extrusion technique (LUVET), thereby taking the additional advantage of the very slow CHL exchange in these vesicles (3) and a fairly homogeneous size distribution of vesicles prepared this way (10).

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- [14C]CHL and [14C]DOPC were from Amersham Corp. DOPC was from Sigma, and bovine heart cardiolipin, DMPC, Tween 20, and CHL from Serva. The alpha -branched fatty acids for the PC(m,n) synthesis were provided by Condea-Chemie (Hamburg, Germany).

P450SCC, adrenodoxin, and adrenodoxin reductase were purified from bovine adrenocortical mitochondria to electrophoretic purity using specific affinity adsorbents (11, 12). They were stored until use at -80 °C in relatively high concentrated form in 50 mM phosphate buffer containing 1 M NaCl, 0.3% sodium cholate, 1 mM EDTA, and 20% (v/v) glycerol. Before use proteins were dialyzed into side chain cleavage assay buffer, aliquoted into small vials, and frozen at -80 °C (standard buffer, 20 mM Hepes, pH 7.3, 50 mM KCl, 0.1 mM dithiothreitol).

The three diacyl-PCs containing branched fatty acids were synthesized and purified according to the method as described in Ref. 13. The compounds were analyzed with fast atom bombardment-mass spectrometry and 1H and 13C NMR and characterized by NMR and Langmuir-Blodgett monolayer investigations. NMR revealed a different headgroup orientation as compared with PC with only two straight chains. LB analysis showed larger lift-off areas and tighter acyl-chain packing at the collapse point than DMPC (13).

Preparation and Characterization of P450SCC-containing Vesicles-- Large unilamellar vesicles were prepared by extrusion of lipid suspensions through filters of convenient size according to the procedure described in Ref. 10. Briefly, 12 mg of the phospholipid(s) in organic solvent were mixed with usually 6 mol % (of total lipid) CHL including a small amount of [14C]CHL in absolute ethanol in a test tube, and solvents were evaporated under N2 and kept under vacuum for 4 h. After complete removal of the solvent 3 ml of standard buffer were added and vortexed. Then the suspensions were taken through five freeze/thaw cycles and extruded 10 times through two stacked polycarbonate filters having pore size of 100 nm (Nucleopore) using a thermobarrel extruder (Lipex Biomembranes Inc., Vancouver, BC, Canada). The extruder was thermostated at 30 °C for DMPC vesicles.

Size and homogeneity of the vesicle preparations were quantitated by light scattering using the methods of cumulants as described earlier (14). An average size could be determined to be about 97 nm in diameter similar to values determined previously (10). The parameter Q characterizing the variance of the size distribution is around 0.25. The particle size and size distribution as well as possible changes upon storage were checked by gel chromatography using Sephacryl S-1000. The vesicles were stable in relation to their size and size distribution within the same day when they were used after preparation.

Reconstitution of P450SCC into the preformed vesicles was done according to Refs. 15 and 16 by incubation of the LUVETs (final concentration, 600 µM) with P450SCC (final concentration, 1 µM) or at any other desired lipid/protein ratio, except that the incubation was done for 5 min at 37 °C. Incorporation of the P450SCC could be evidenced by gel chromatography using Sepharose 4B (Pharmacia Biotech Inc.).

Stopped Flow Kinetics of Incorporation of P450SCC into Vesicles-- Stopped flow measurements were conducted at 21 °C using a computer-controlled Sequential Stopped Flow ASVD Spectrofluorimeter DX-17 MV (Applied Photophysics). According to Ref. 4 we measured the spectral changes caused by the high spin to low spin spectral transition following association of the enzyme with the membrane of vesicles to monitor the rate of incorporation of P450SCC into vesicles. Usually kinetic runs were performed at two wavelengths, 393 (high spin peak) and 415 nm (low spin peak), followed by analysis of the difference absorption curve A393-A415. Thus the net spin change was measured. Typically, two to five runs were performed and accumulated to improve the signal to noise ratio. Mixing of P450SCC (with bound CHL) with LUVETs was conducted with syringe A containing 1.4 µM P450SCC in standard buffer. Syringe B contained 1.7 mM total phospholipid (including 6 mol % CHL) in the same buffer. Data analysis was done using the Kinetic Spectrometer Workstation Software package provided by the manufacturer.

Optical Titrations-- All optical spectra were recorded on a double-beam UV2101-PC spectrophotometer (Shimadzu, Japan). Complexation of the substrate CHL with P450SCC was monitored by following changes in the Soret maximum at 415 nm (low spin, substrate-free) and at 393 nm (high spin, substrate-bound) according to Ref. 17. Usually difference spectra were followed with P450SCC (2 µM) in 0.1% Tween 20, 20 mM Hepes, pH 7.3, 0.1 mM dithiothreitol, 50 mM KCl, and the appropriate concentration of the branched PCs in the sample cuvette and the same without the protein in the reference cuvette.

Enzymatic Activity and P450SCC Exchange Experiments-- Activity of P450SCC was determined as side chain cleavage activity of CHL to produce pregnenolone according to the following assay: 0.25 µM P450SCC and 7 µM adrenodoxin in standard buffer were incubated at 37 °C for 10 min with vesicles consisting of 400 µM phospholipid with 6 mol % CHL including [14C]CHL in a total volume of 0.5 ml. 0.25 µM adrenodoxin reductase was added, and the reaction was initiated by the addition of 2.5 mM NADPH (to a final concentration of 250 µM). After 5 min the reaction was terminated by the addition of 0.1 ml of 0.5 N HCl. The residual substrate and the product were extracted with 2 × 2 ml of methylene chloride, and pregnenolone was separated from unreacted CHL by thin layer chromatography on silica gel 0.25 mm, 20 × 20 cm (Merck) using a solvent mixture of n-hexane/petroleum ether/acetic acid (15:15:1, by volume). Analysis was done by counting the 14C radioactivity of CHL and pregnenolone using a Linear Analyzer LB284 (Berthold). Unless stated otherwise, each analysis was done three times to ensure reproducibility within a standard error of less than 10%.

The P450SCC exchange between vesicles was monitored by an metabolic assay according to the following procedure: Primary DOPC-LUVETs were prepared containing 10 mol % CHL and P450SCC according to the description given above; an equal amount of secondary vesicles was prepared in the same manner but without P450SCC. Three series of experiments were conducted: (i) to measure the activity in primary vesicles, [14C]CHL was included in the primary vesicles, (ii) to measure the activity in the secondary vesicles [14C]CHL was included in the secondary vesicles, and (iii) to measure the total activity [14C]CHL was included in both classes of vesicles. After preincubation of the primary vesicles with adrenodoxin and adrenodoxin reductase for 20 min at room temperature and 5 min at 37 °C, the reaction was initiated by addition of the secondary vesicles and NADPH. To analyze the time dependence each series of experiments was carried out in parallel 4-fold, terminating the reaction at 1,2, 3, and 5 min by HCl as described above.

Analytical Methods-- The concentration of P450SCC was determined from reduced CO minus reduced difference spectra using a difference extinction coefficient of 91 mM-1 for A450 - A490 according to Ref. 18. The concentrations of adrenodoxin reductase and adrenodoxin were determined using extinction coefficients of 10.9 mM-1 at 450 nm and 11 mM-1 at 415 nm, respectively (19). CHL and lipid were quantitated using 14C-labeled CHL and 14C-labeled DOPC, respectively.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Effect of Branched PCs on the Activity of P450SCC in DMPC- and DOPC-LUVETs-- Fig. 1 shows the activity of P450SCC in vesicle preparations containing either pure DMPC or DOPC and mixtures of both lipids with PC(m,n) and CL. Structural formulas for the PC(m,n) can be found in Refs. 8 and 9. The data demonstrate the effect of increasing membrane content of the branched PC(m,n) and CL, respectively. In each case the total phospholipid concentrations (in weight%) remained the same. To facilitate direct comparison of the results with previous data, values were normalized to 100% maximum activity. The 100% value correspond to 5.8, 6.0, 6.5, 4.6, 5.3 nmol pregnenolone/min/nmol P450SCC for DMPC/PC(10,6), DMPC/PC(12,8), DMPC/PC(14,10), DMPC/CL, and DOPC/PC(14,10), respectively. In DMPC vesicles, the rate of pregnenolone formation increases with the proportion of PC(14,10) from a turnover number of 0.45 min-1 in the absence of PC(14,10) to 6.5 min-1 with 47 mol % PC(14,10). In DMPC vesicles containing CL, activity also increases with the proportion of CL reaching a maximum corresponding to 15-fold stimulation at about 19 mol % CL. The latter result is consistent with previous findings for CL in sonicated DMPC and DOPC vesicles (5, 7).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of branched PC(m,n) on the rate of cholesterol side chain activity of P450SCC in DMPC- and DOPC-LUVETs and effect of CL on the activity in DMPC-LUVET. black-square, PC(10,6) in DMPC; square , PC(12,8) in DMPC; bullet , PC(14,10) in DMPC; open circle , CL in DMPC; black-diamond , PC(14,10) in DOPC. For each data point, vesicles were prepared consisting of a mixture of PC(m,n) and DMPC (or DOPC) and containing in a molar ratio 0.06 mol cholesterol/mol total lipid. The latter was the same for all preparations. P450SCC was reconstituted into vesicles containing increasing content of PC(m,n) or CL. For reconstitution of P450SCC into the preformed vesicles and the assay conditions, see the description under "Experimental Procedures." Each analysis was done three times to ensure reproducibility within a standard error of less than 10%.

Effect of PC(14,10) on Binding of CHL to P450SCC in DMPC- and DOPC-LUVETs-- The CHL dependence of the activity in DMPC and DOPC vesicles without and with different membrane content of PC(14,10) showed normal Michaelis-Menten saturation behavior. Kinetic parameters determined from the Lineweaver-Burk plots of Fig. 2 are summarized in Table I. According to Ref. 16 we plotted the (inverse) activities versus the lipid/CHL ratio because CHL is present only in the membrane. In pure DOPC we found two phases, a slow phase and a fast phase at higher content of CHL. The latter is characterized by a nearly 7-fold enhanced Vmax. However, the fast phase is characterized by an increased Km value characterizing less CHL binding. As evident from the Fig. 2 for both vesicle systems the effect of increasing the amount of PC(14,10) results in diminishing of the slow phase. The stimulatory effect then resulted from a decrease in Km rather than from a change in Vmax, which remains at the high value observed for the fast phase. However, the binding of CHL is characterized by an intermediate Km value. It is interesting that a sufficiently high membrane content of PC(14,10) in DMPC leads to identical kinetic parameters as measured for the DOPC vesicle systems. Pure DMPC vesicles were not used because activities are relatively low. Because of the high Km values for CHL in this lipid, near saturating levels of CHL cannot be achieved, and determination of Vmax is almost impossible.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Cholesterol dependence of the activity of P450SCC in DMPC- and DOPC-LUVETs with different content of PC(14,10). bullet , DOPC; black-square, DOPC/PC(14,10) (2:1,w/w); open circle , DMPC/PC(14,10) (2:1,w/w); square , DMPC/PC(14,10) (1:1,w/w); (1), slow phase; (2), fast phase; PG, pregnenolone. Preparation and assay conditions were the same as those described in the legend to Fig. 1; however, varying concentrations of cholesterol were used. Each point represents the mean of three determinations.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Kinetic parameters for the cholesterol side chain cleavage activity of P450SCC in vesicle systems containing PC(14,10)
Conditions are as described in the legend of Fig. 2. The mean and standard deviation of three determinations with the same P450SCC and vesicle preparation are shown.

Effect of Branched PCs and CL on CHL Binding to P450SCC in Tween 20 Solution-Optical Titration Experiments-- Preliminary results obtained in DOPC vesicle systems suggested that the stimulation of P450SCC activity by branched PCs is correlated with the fraction of the enzyme in the high spin form (8) as has been discussed earlier for CL and other activator lipids (5-7). The complexation of CHL with P450SCC causes a conversion of heme iron from the low spin to the high spin form, which can be monitored in the Soret region of the absorption spectrum (17, 6). However, the vesicle-reconstituted system was not ideal for quantitative analysis based on optical binding experiments because of the varying turbidities in the different vesicle preparations. Thus we used a mixed detergent (Tween 20)-lipid system in the optical titration experiments with the branched PC(m,n) and CL. Due to the dilution of CHL in the detergent, the addition of detergent results in almost complete conversion of P450SCC to the low spin form (Fig. 3, inset, solid line), whereas addition of a branched PC results in partial conversion of P450SCC to the high spin form (Fig. 3, inset, dotted line). At constant CHL and Tween 20 concentrations, increasing quantities of the branched PCs in the micellar system produced increasing fractions of P450SCC in the high spin form. Titrations of the enzyme with branched PC(m,n) and CL were performed; Fig. 3 demonstrates the saturation behavior for PC(12,8), which is typical for all other branched PCs and CL, too. To estimate the potency of a certain branched PC for induction of the high spin state of P450SCC, we calculated parameters from curves like that of Fig. 3 corresponding to the lipid concentration causing half-maximal spin shift. They are 30, 25, and 18 µM for PC(10,6), PC(12,8), and PC(14,10), respectively. Thus, the potency is increasing in the order PC(14,10) > PC(12,8) > PC(10,6). These changes in the high spin shift potency were paralleled by a similar order in the potential of the branched PCs to activate P450SCC, as can be seen from a comparison with the curves of Fig. 1.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   PC(12,8)-induced spin state changes of P450SCC in Tween 20 solution. The curve demonstrates the conversion of P450SCC from the low to the high spin form in the presence of increasing concentration of PC(12,8) in Hepes buffer, pH 7.3, 0.1 mM dithiothreitol, 50 mM KCl containing 0.1% Tween 20. The P450 concentration was 1 µM, and the CHL concentration was 150 µM. The spin shift was quantitated as Delta A - Delta Ao, where Delta Ao and Delta A represent the absorbance difference 415-393 nm without and with lipid, respectively. Data are expressed as the increase in high spin shift as a percentage of the maximum high spin shift at saturation. 100% correspond to an absorption change of 0.04. Each data point represents the mean of three determinations. Inset, absorption spectra of P450SCC without (solid line) and with (dotted line) PC(12,8).

Effect of PC(14,10) on the Incorporation of P450SCC into DOPC- and DMPC-LUVETs-- The association of P450SCC with the membrane of phospholipid vesicles during ultracentrifugation and gel chromatography is a well known fact indicating a high affinity for the membrane (e.g. Refs. 7, 15, 20). We analyzed the extent of P450SCC incorporation into LUVETs by gel chromatography using Sepharose 4B. Free, unbound P450SCC was retained at more than twice the elution volume of LUVETs of about 100 nm in diameter that elute near Vo of the Sepharose column (Fig. 4). When incorporated into LUVETs P450SCC coelutes with the vesicles. The curves of Fig. 4 demonstrate the effect of increasing membrane content of PC(14,10) on the incorporation of the protein. Increasing membrane content of PC(14,10) caused increasing amounts of P450SCC to be incorporated into the vesicles. For DOPC above a concentration of PC(14,10) of 20 mol % (and for DMPC above 30 mol %) almost all P450SCC is associated with the membrane, and no P450SCC elutes at a position where free, unbound protein was expected. Usually about 70% protein and almost all lipid were recovered from the column. The shown profile of vesicle elution monitored with [14C]DOPC as marker for lipid was typical for all preparations independent of the membrane content of PC(14,10). The data were summarized and represented for both DOPC and DMPC in Fig. 5 to facilitate direct comparison with the data from the activity measurements in Fig. 1. Clearly, the increased membrane incorporation efficiency of P450SCC induced by PC(14,10) is paralleled by a similar enhancement in its activity.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Elution profiles of P450SCC-containing DOPC-LUVETs of varying membrane content of PC(14,10) by gel chromatography using Sepharose 4B. Thin line without symbol, lipid; open circle , 0 mol % P450SCC; black-square, 10 mol % P450SCC; ×, 20 mol % P450SCC; square , 30 mol % PC(14,10). LUVETs were prepared as described under "Experimental Procedures" at 5 mg/ml total lipid, containing 6 mol % CHL and [14C]CHL or [14C]DOPC as marker for CHL and lipid. Vesicles (2 mg of lipid) were incubated with 4 nmol P450SCC in 0.87 ml 20 mM Hepes, pH 7.3, 0.1 mM dithiothreitol, 50 mM KCl for 5 min at 37 °C, chilled in ice water, and applied to the column. The line with filled circles (bullet ) represents the elution profile of (free) P450 applied to the column in a separate experiment. Fractions were analyzed spectrophotometrically for P450SCC (A(420)) and by monitoring the radioactivity for the lipid. For clarity only one curve for lipid is shown.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of PC(14,10) on the membrane incorporation of P450SCC into DOPC- and DMPC-LUVETs. The symbols represent the percentage of membrane-bound enzyme for the same samples described in Fig. 1. Bound P450SCC was determined from the elution profile after Sepharose 4B chromatography performed as described in the legend to Fig. 4 for DOPC. Simple summation of the P450SCC content of the vesicle peak fractions and the free P450 fractions yielded the fraction of bound and unbound P450SCC, respectively. The inserted table shows the relative distribution of P450SCC between the membrane-bound and free, unbound state and the total amount incorporated for DOPC vesicles.

Effect of Branched PCs and CL on the Kinetics of P450SCC Incorporation into DOPC-LUVET-- The rate of incorporation of P450SCC into the membrane of vesicles can be directly monitored by measuring the spectral changes caused by the CHL transfer off from P450SCC to the membrane (4, 7). This transfer of CHL is accompanied by the high to low spin spectral change. Stopped flow experiments were performed to measure the kinetics of incorporation of P450SCC into DOPC-LUVETs containing any of the branched PC(m,n) and CL. In Fig. 6 the kinetic traces resulting from such an experiment for pure DOPC and DOPC containing 30 mol % PC(10,6) are shown as typical examples. Rates of association of P450SCC with the vesicles and the extent of the spectral spin shift were determined from fits of the experimental curve by one or two exponential functions (Table II). The rate of incorporation of P450SCC as well as the extent were found dependent on the phospholipid composition of the vesicles. Pure DOPC vesicles incorporated P450SCC in a single phase process exhibiting first order kinetics at a relatively slow rate. It can be seen from the lower total extent compared with the other systems that P450SCC was not completely incorporated into the membrane. When the vesicle systems contained PC(m,n) a biphasic incorporation reaction and complete incorporation were found at higher mole fractions of the nonbilayer lipids. For all three branched PCs, fits with two exponentials were significantly better, indicating a two phase reaction of the incorporation process. However, in the case of CL-containing membranes the analysis could not be performed in a unique manner; analysis with two exponentials gave no apparently better fit, as it was in the case of the branched PCs. In general, fast and slow reaction phases differ in their rates by approximately 1 order of magnitude. The extent of the fast phase was between 55 and 70% and was dependent on the membrane content of the branched PC. This dependence was studied further for PC(14,10). It can be seen clearly from the data that increasing the PC(14,10) in the membrane did not change either the biphasicity nor the rates of the process. On the other hand, increasing PC(14,10) content of the membrane produced a higher portion of P450SCC to be incorporated into the membrane in the fast phase. This does not occur at the expense of the slow phase, it rather seems that an increasing content of branched PC(14,10) causes an approximately 30% higher portion of total P450SCC to be associated with the membrane. Note that a similar observation was made in the (stationary) incorporation experiments based on gel chromatography.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Stopped flow kinetic run of the incorporation of P450SCC into the membrane of DOPC-LUVETs. Lower trace, pure DOPC; upper trace, with 30 mol % PC(10,6). The data represent the difference of absorbance at 393 and 415 nm in dependence on the time in seconds. The curves are averages of three runs each. Records were performed as described under "Experimental Procedures." Experimental data were best fitted by a sum of two exponential functions for DOPC/PC(10,6) (upper trace) and a single exponential for DOPC (lower trace) as described in the legend of Table II. Fits are shown by the smooth curves. For clarity the curves were displaced with regard to the y axis. The lower part of the figure represents residuals of the fitted minus experimental data for DOPC/PC(10,6) at an enlarged scale.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Stopped flow kinetics of P450SCC incorporation into DOPC-LUVET containing branched PCs and CL
After mixing the concentration of P450SCC was 0.7 µM, the molar lipid/protein ratio was 1200. 

Effect of branched PC(14,10) and CL on the Metabolism of CHL in Secondary DOPC-LUVET and P450SCC Exchange-- To analyze the effect of branched PCs and CL on the P450SCC exchange between vesicles, the metabolism of CHL was measured in primary and secondary vesicles. According to Ref. 3 CHL exchange between vesicles is very slow with regard to the time scale of the enzymatic activity assay, particularly in the LUVETs used in our experiments (21). Thus, P450SCC incorporated in one class of vesicles (e.g. primary) can only metabolize CHL in the other (e.g. secondary vesicles) after exchange between the vesicles. Fig. 7A clearly shows an almost concomitant increase of the CHL metabolism in primary and secondary vesicles with the rate decreasing a little after 3 min, demonstrating very rapid exchange of P450SCC between DOPC-LUVETs. When the phospholipid composition in both primary and secondary vesicles was changed by inclusion of 30 mol % PC(14,10) we observed a rapid exchange similar to that in pure DOPC and a pronounced enhancement of the CHL metabolism caused by the stimulating potency of the branched PC (Fig. 7B). After 1-2 min the metabolic rate in secondary vesicles seems a little bit decreased. However, the absence of any delay time in the metabolism of the secondary vesicles indicates a rapid P450SCC exchange between primary and secondary vesicles. Inclusion of CL in primary and secondary vesicles, however, results in completely different metabolic behavior (Fig. 7C). The metabolism in secondary vesicles only slowly increases with time, exhibiting a lag time of about 3 min. Nevertheless, total metabolism is high and is realized almost completely in primary vesicles. Even after 5 min, the pregnenolone produced is almost five times less than in primary vesicles, indicating at least partial inhibition of P450SCC exchange in DOPC/CL-LUVETs.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of PC(14,10) and CL on the cholesterol metabolism in primary and secondary DOPC-LUVETs. A, pure DOPC; B, DOPC/PC(14,10) (30 mol %); C, DOPC/CL (15 mol %). [14C]CHL was included as marker in primary or secondary vesicles or both vesicle classes to monitor the metabolism in primary vesicles (bullet ), in secondary vesicles (open circle ), and the total metabolism (black-square). P450SCC was preincubated with primary vesicles, adrenodoxin, and adrenodoxin reductase, and the reaction was initiated by concomitant addition of secondary vesicles and NADPH. P450SCC, 0.25 µM; CHL, 10 mol % of total phospholipid; molar lipid/protein ratio, 1200. For all other conditions see under "Experimental Procedures." Each data point is the mean of three measurements.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Data represented here for LUVETs and in our preliminary previous report for sonicated vesicles (8) show that an exceptionally high stimulation of the side chain activity of P450SCC can be obtained in phospholipid vesicles containing branched PCs as a membrane constituent. The observed activation was found to increase with the mole percent of branched PC and the lengths of both the branched and main fatty acyl chains, i.e. in the order PC(14,10) > PC(12,8) > PC(10,6). The observed rates (Vmax > 30 min-1) are only comparable with the highest rates reported so far for micellar systems using Tween 20 as detergent (17, 19) and for DOPC vesicle systems prepared by octylglucoside dialysis (2). In the latter case the high activity results from residual octylglucoside. In the paper presented we studied three of several ways in which the membrane can modulate the activity of P450SCC: (i) direct stimulation of the activity by P450SCC-CHL interaction, (ii) changes in the integration of P450SCC with the lipid bilayer, and (iii) exchange of P450SCC between vesicles as additional factor controlling the rate of CHL substrate accessibility to P450SCC. Because very small impurities and vesicle size heterogeneity affect these properties, all studies were performed with extruder-reconstituted vesicles providing large unilamellar vesicles relatively uniform in size and free of any impurity. The general conclusion is that all three properties of P450SCC, i.e. interaction with CHL substrate, membrane integration, and protein exchange, were enhanced by branched PCs and therefore may contribute to the observed high activation of P450SCC by branched PCs.

Branched PCs stimulate in a qualitatively similar manner the rate of P450SCC-CHL complex formation in both DOPC and DMPC vesicles. In general, activities in DMPC are very low, a finding reflecting the well known decreased Km for CHL in DOPC (7, 16). However, DMPC vesicles containing a low portion of branched PC behave similar to pure DOPC vesicles. In both systems activity is characterized by a biphasic nature. At lower CHL content (phase 1, lipid/CHL ratio > 5-7) the activity in both systems is characterized by a Vmax of ~5-8 min-1 and a small Km of ~0.05. At higher CHL content phase 2 occurred (lipid/CHL > 5-7) with a significantly enhanced Vmax of >= 30 min-1, but a high Km of ~0.9. Activities are nearly equal in both vesicle systems at higher portions of branched PC in the membrane. Considerable membrane content of branched PC results in diminishing of the phase characterized by low Vmax value. A new type of fast activity phase 2 occurred indicated by the same very high Vmax of the fast phase 2 and corresponding to a relatively low Km (~0.2). The similarity in the activity dependence of pure DOPC and DMPC vesicles containing a low portion of branched PC tempted us to conclude that CHL and branched PCs in some way act similarly and additively. Both compounds seem to impact the membrane with the same structural property leading to activation of P450SCC via enhancement of CHL binding to P450SCC. Biphasicity in activity is not new; it has been already reported earlier for octylglucoside-reconstituted DOPC vesicles and interpreted as resulting from residual octylglucoside (2). An additional second phase of complex formation also has been reported for DMPC/CL vesicles (7). In contrast to the latter observation, in Ref. 5 it has been reported that phospholipids including CL exert their effect by a monophasic process decreasing Km for CHL leaving Vmax unchanged. The above mentioned sensitivity of P450SCC properties to very small impurities and vesicle size heterogeneity may in part explain the diversity of previous studies obtained using vesicles prepared by sonication and/or detergent dialysis.

Direct evidence for branched PC-induced enhancement in the P450SCC-CHL complex formation could be provided by the optical titration experiments. Branched PCs cause an increase in the fraction of P450SCC in high spin conformation reflecting an increased P450SCC-CHL complex formation. The potency of the distinct branched PCs in the induction of the P450SCC-CHL complex formation parallels the same order in which the three branched PCs stimulate activity, i.e. in the order PC(14,10) > PC(12,8) > PC(10,6). Taking together these results and the data from enzymatic assays, it is evident that branched PCs and CL stimulate both the CHL binding to and the activity of P450SCC, i.e. the potency to stimulate the activity of P450SCC is correlated with the enhancement in the fraction of the enzyme in the high spin form. The results suggest our previous conclusion that the hydrophobic volume of the branched PCs is an important determinant of the P450SCC-lipid interaction (8, 9).

An important aspect of the reported studies is the finding that branched PCs increase the membrane incorporation efficiency of P450SCC. Our results demonstrate that an increase in the enzymatic activity of P450SCC caused by branched PCs as membrane constituents is paralleled by an increase in the fraction of membrane-bound enzyme. This demonstrates that the changes in P450SCC activity reflect at least partially an altered degree of the membrane incorporation of P450SCC. On the other side, this cannot account for all activation because even after P450SCC incorporation is complete further stimulation in the activity was found, i.e. increase in the activity of the membrane-bound form of the enzyme. Contrary to our data, occasionally complete membrane incorporation of P450SCC has been reported for DOPC vesicles. This is probably due to heterogeneity with regard to size vesicle preparations used in most cases. Previous reports and our own preliminary experiments show that the degree of P450SCC integration with the membrane also depends on the vesicle size with the tendency to be higher in smaller vesicles (4, 22, 23).

The kinetics of P450SCC incorporation into DOPC vesicles studied by stopped flow experiments showed a biphasic nature of the process when branched PCs are present in the membrane, whereas incorporation proceeds monophasically in pure DOPC. Moreover, the fast phase occurred with a rate about 3-fold faster than observed with pure DOPC where the reaction is monophasic and relatively slow. The fast phase for all three branched PCs was about double compared with the slow phase. Increasing amounts of branched PCs substantially increased the extent of the fast phase incorporation, whereas the rate was independent of the branched PC content. Monophasicity and first order kinetics for the association of P450SCC with a membrane have been earlier reported for sonicated DOPC vesicles (4, 7). However, for CL-containing DOPC vesicles Kowluru et al. (7) reported an additional fast phase with a significantly greater rate constant and an extent equal to the slow phase. As already mentioned above, on the basis of our data we could not unambigously conclude on a second phase in the case of DOPC-LUVETs containing CL. The biphasic nature of the incorporation reaction found in the presence of branched PCs may be due to several aspects of the process, such as P450SCC-membrane interaction, the extent of insertion required for optimal P450SCC-CHL complex formation, or the miscibility of the different lipid components of the membrane, i.e. lateral distribution of the membrane components. Branched PCs may both accelerate incorporation and increase CHL transfer off (and on) P450SCC by providing either an optimal integration (penetration) in the membrane or domains more or less enriched in branched PCs and/or CHL, which could result in activation. Particularly the latter point must be considered as a possible explanation because recent calorimetric investigations of the thermotropic behavior of DMPC/PC(14,10) dispersions demonstrated a significantly destabilized bilayer structure of the membrane and existence of a second phase at higher PC(14,10) contents. This might be related to separated membrane domains enriched in PC(14,10) and/or CHL (9).

Lastly, the present study establishes that P450SCC exchanges rapidly between DOPC-LUVETs and that inclusion of branched PCs results in even more rapid exchange, whereas CL significantly inhibits P450SCC exchange. Although earlier reports denied P450SCC exchange in soy PC vesicles (15), later such an exchange was found for DOPC vesicles and explained by the specific capacity of P450SCC to bridge between two vesicle membranes thereby using two distinct domains on the protein (3). One domain must be at least partially overlap with the adrenodoxin binding region, probably involving positively charged regions on P450SCC (3, 24). Note that we never observed a lag time for metabolism in secondary DOPC vesicles as reported for small unilamellar DOPC vesicles (3). Moreover, the P450SCC exchange was rapid enough to make the metabolism in primary and secondary vesicles almost equal (Fig. 7A). This again points onto the role that vesicle size (i.e. membrane curvature) may play in such processes. Our finding that CL inhibits the exchange significantly is in accordance with the previously reported observation that acidic phospholipids such as phosphatidic acid greatly slow down P450SCC exchange (3). Because our stopped flow experiments suggest a different nature for the incorporation process for CL, this latter finding may indicate partial inhibition of P450SCC caused by stronger integration of the enzyme in the DOPC/CL membrane.

In conclusion, our study identified and characterized several properties of P450SCC in vesicle systems that are influenced by branched PCs and/or CL. We believe that the results may contribute to a better understanding of the regulation of the P450SCC activity in mitochondria, because all, or at least some, processes studied in vesicle systems may play a role in mitochondria, too. We would like to note the highly curved vesicle structures of the inner mitochondrial membrane and its induction by enhanced P450SCC synthesis reported long ago (25, 26). The P450SCC-membrane interaction is certainly more complex than the original classical concept has been anticipated of phospholipids being cofactors binding specifically to the enzyme. Beside the negative charge of anionic lipids such as CL, there is probably an important role for physical properties of the membrane including the nonbilayer phase propensity (9, 27, 28) and lateral distribution of nonmiscible membrane constituents, which may control P450SCC conformation, P450SCC membrane incorporation, and the accessibility of the CHL substrate. There is increasing evidence that the role of lipids in the regulation of the functions of membrane-bound proteins can be assessed only by taking all of the factors into account (29).

    ACKNOWLEDGEMENTS

We thank Drs. K. Gast and D. Zirwer (Max Delbrueck Center) for dynamic light scattering experiments, as well as A. Sternke for technical assistance during all the experimental work. The gift of the alpha -branched fatty acids from Condea-Chemie (Hamburg, Germany) is greatly appreciated.

    FOOTNOTES

* This work was supported by Grant Schw 471/1-3 from the German Research Foundation (DFG) and Grant I/71 491 from the Volkswagen-Stiftung (to D. S. and P. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Max Delbrueck Center for Molecular Medicine, Robert Roessle Str. 10, D-13125 Berlin-Buch, Germany. Fax: 49-30-949-3329; E-mail: schwarz{at}orion.rz.mdcberlin.de.

1 The abbreviations used are: CL, cardiolipin; P450SCC, cytochrome P450SCC (CYP11A1); PC, phosphatidylcholine; DMPC, dimyristoyl-PC; DOPC, dioleoyl-PC; CHL, cholesterol; PC(m,n), branched 1,2-diacyl PC; PC(10,6), 1,2-di-[(2'-hexyl)decanoyl]-PC; PC(12,8), 1,2-di-[(2'-octyl)dodecanoyl]-PC; PC(14,10), 1,2-di-[(2'-decyl)tetradecanoyl]-PC; LUVET, large unilamellar vesicles prepared by extrusion techniques.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Lambeth, J. D. (1990) in Frontiers in Biotransformation: Molecular Mechanisms of Adrenal Steroidogenesis and Aspects of Regulation and Application (Ruckpaul, K., and Rein, H., eds), Vol. 3, pp. 58-100, Akademie Verlag, Berlin
  2. Dhariwal, M. S., and Jefcoate, C. R. (1989) Biochemistry 28, 8397-8402[Medline] [Order article via Infotrieve]
  3. Dhariwal, M. S., Kowluru, R. A., and Jefcoate, C. R. (1991) Biochemistry 30, 4940-4949[Medline] [Order article via Infotrieve]
  4. Tuckey, R. C., and Kamin, H. (1982) J. Biol. Chem. 257, 2887-2893[Free Full Text]
  5. Lambeth, J. D. (1981) J. Biol. Chem. 256, 4757-4762[Medline] [Order article via Infotrieve]
  6. Pember, S. O., Powell, G. L., and Lambeth, J. D. (1983) J. Biol. Chem. 258, 3198-3206[Free Full Text]
  7. Kowluru, R. A., George, R., and Jefcoate, C. R. (1983) J. Biol. Chem. 258, 8053-8059[Abstract/Free Full Text]
  8. Schwarz, D., Kisselev, P., Wessel, R., Jueptner, O., and Schmid, R. D. (1996) J. Biol. Chem. 271, 12840-12846[Abstract/Free Full Text]
  9. Schwarz, D., Kisselev, P., Pfeil, W., Pisch, S., Bornscheuer, U., and Schmid, R. D. (1997) Biochemistry 36, 14262-14270[CrossRef][Medline] [Order article via Infotrieve]
  10. Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Biochim. Biophys. Acta 858, 161-168[Medline] [Order article via Infotrieve]
  11. Chashchin, V. L., Vasilevsky, V. I., Shkumatov, V. M., Akhrem, A. A. (1984) Biochim. Biophys. Acta 787, 27-38[Medline] [Order article via Infotrieve]
  12. Usanov, S. A., Chernogolov, A. A., and Chashchin, V. L. (1987) Biochemistry (USSR) 52, 110-122
  13. Ruerup, J., Lauer, F., Drewes, A., Wray, V., and Schmid, R. D. (1994) Chem. Phys. Lipids 72, 175-183[Medline] [Order article via Infotrieve]
  14. Schwarz, D., Zirwer, D., Gast, K., Meyer, H. W., Coon, M. J., Ruckpaul, K. (1988) Biomed. Biochim. Acta 47, 609-621[Medline] [Order article via Infotrieve]
  15. Seybert, D. W., Lancaster, J. R., Jr., Lambeth, J. D., Kamin, H. (1979) J. Biol. Chem. 254, 12088-12098[Abstract]
  16. Lambeth, J. D., Kamin, H., and Seybert, D. W. (1980) J. Biol. Chem. 255, 8282-8288[Abstract/Free Full Text]
  17. Takikawa, O., Gomi, T., Suhara, K., Itagaki, E., Takemori, S., and Katagiri, M. (1978) Arch. Biochem. Biophys. 190, 300-306[Medline] [Order article via Infotrieve]
  18. Omura, T., and Sato, R. (1964) J. Biol. Chem. 239, 2370-2378[Free Full Text]
  19. Hanukoglu, I., Pridalle, C. T., and Jefcoate, C. R. (1981) J. Biol. Chem. 256, 4329-4335[Free Full Text]
  20. Hall, P. F., Watanuki, M., and Hamkalo, B. A. (1979) J. Biol. Chem. 254, 547-552[Abstract]
  21. Thomas, P. D., and Pozansky, M. J. (1988) Biochem. J. 254, 155-160[Medline] [Order article via Infotrieve]
  22. Yamakura, F., Kido, T., and Kimura, T. (1981) Biochim. Biophys. Acta 649, 343-354[Medline] [Order article via Infotrieve]
  23. Schwarz, D., Richter, W., Krueger, V., Chernogolov, A., Usanov, S., and Stier, A. (1994) J. Struct. Biol. 113, 207-215[CrossRef][Medline] [Order article via Infotrieve]
  24. Wada, A., and Waterman, M. R. (1992) J. Biol. Chem. 267, 22877-22882[Abstract/Free Full Text]
  25. Farkash, Y., Timberg, R., and Orly, J. (1986) Endocrinology 118, 1353-1365[Abstract]
  26. Nussdorfer, G. G. (1986) Int. Rev. Cytol. 98, 1-78[Medline] [Order article via Infotrieve]
  27. Gruner, S. M., Cullis, P. R., Hope, M. J., Tilcock, C. P. S. (1985) Annu. Rev. Biophys. Chem. 14, 211-238[CrossRef][Medline] [Order article via Infotrieve]
  28. Hui, S.-W., and Sen, A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 5825-5829[Abstract]
  29. Mosior, M., Golini, E. S., and Epand, R. M. (1996) Proc. Natl. Acad. Sci U. S. A. 93, 1907-1912[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.